Assessment of the licensing and patenting practices of UK's leading medical research institutions

Sarai Keestra made this Freedom of Information request to University of Liverpool

This request has been closed to new correspondence from the public body. Contact us if you think it ought be re-opened.

The request was successful.

Dear University of Liverpool,

The FOI request below is being filed on behalf of UAEM-UK. Please note that the answers to these questions will be used to determine the university’s score in the forthcoming Global Health Ranking of leading UK universities by Universities Allied for Essential Medicines (UAEM) UK.

We encourage you to read this background briefing before compiling your response:
https://docs.google.com/document/d/1GMzH...

Thank you very much for your time & best wishes,
Sarai Keestra - Universities Allied for Essential Medicines UK

START FOI

For the purpose of clarity, please adhere to the following definitions when answering these questions:

Definitions

Low and middle income country: A country that is defined as ‘low’, ‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year 2018. Income status defined by GNI per capita.
Source: World bank, available online [https://tinyurl.com/jr6s6fm]

Patent: A form of intellectual property (IP) rights protection, whereby a government grants to the inventor, the right to stop others from making, using or selling the product without their permission for a limited period.
Source: Upcouncil, available online [https://www.upcounsel.com/copyright-trad...

Licence: Contracts that transfer IP rights from the owner of the rights to a third party for use.
Source: Upcouncil, available online [https://www.upcounsel.com/copyright-trad...

Exclusive Licence: A licence that allows only the named licensee to exploit the relevant IP rights, the licensor is also excluded from exploiting these IP rights.
Source: TaylorWessing, available online [https://united-kingdom.taylorwessing.com...

Non-Exclusive Licence: A licence that grants any number of licensees to exploit the IP.
Source: TaylorWessing, available online [https://united-kingdom.taylorwessing.com...

Health Technology: ‘Health technology as defined by the WHO: “A health technology is the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of lives.’ Source: WHO, available online [http://www.who.int/health-technology-ass...

Q1. Has the university committed to licensing its medical discoveries in ways that promote access and affordability in Low- and Middle- Income Countries? If yes, please provide a link or PDF to the relevant policy document.

Q2. Please provide an Excel spreadsheet with headings as displayed below with all the health technologies LICENSED by the university in the past year AND specify which countries they were licensed in AND specify whether they are exclusive or non-exclusive licenses.

Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-Exclusive)

Q3. Please provide an Excel spreadsheet with all the health technologies PATENTED by the university in the past year AND specify which countries they were patented in.

Q4.Has the university shared its best practices for promoting access to medicines through non-exclusive licensing by carrying out any of the following activities?
- Contributed sample clauses to the AUTM Global Health Toolkit
- Published an article, guidance, or other literature on access licensing practices
- Formally presented on access licensing practices at an academic or professional event, or at another university
- Informally shared or discussed access licensing practices with administrators at other universities
- Other
- None
(Tick as appropriate)

Q5. What actions has the technology transfer office (TTO) undertaken in the past year to improve access to the technologies they license in low- and middle-income settings?

END FOI

Yours faithfully,

Sarai Keestra

foi Uof Liverpool, University of Liverpool

Dear Ms. Keestra,

Thank you for your email received 10th October 2018 requesting information about assessment of the licensing and patenting practices of UK's leading medical research institutions. I am writing to let you know that we have received your request and will process it as soon as possible, and in any case within 20 working days of the day we received the request. You will hear back from us by 7th November 2018 at the latest.

Yours sincerely

Mrs Lesley Jackson, FOI Co-ordinator
The University of Liverpool, Foundation Building,
765 Brownlow Hill, Liverpool L69 7ZX

show quoted sections

Dear FOI Uof Liverpool,

It has been pointed out to me that the link to the background briefing in our FOI request was broken. Please accept my sincerest apologies for this inconvenience. This link should now be working: https://docs.google.com/document/d/1GMzH...

Yours sincerely,

Sarai Keestra

David, Laura, University of Liverpool

2 Attachments

Hi Sarai

 

Is there a number I can call to clarify the information you require under
this FOI request?

 

Kind regards

Laura

 

Laura David

IP Associate

 

Liverpool IP

Business Gateway

University of Liverpool

1st floor, Block D

The Waterhouse Building

3 Brownlow St

Liverpool L69 3GL

 

Tel: +44(0) 151 795 5466

 

Building 354 in C9 on the campus map
[1]http://www.liv.ac.uk/files/docs/maps/liv...

 

[2]ip[3]The University of Liverpool   

This is an email from the University of Liverpool. If you do not wish to
receive future emails regarding ‘research business opportunities’ then
please let us know by responding to this email.

 

This e-mail and any attachments are private and confidential. If you are
not the named recipient, please destroy the e-mail and any attachments,
notify the sender immediately and do not disclose the contents to another
person or use them. Any such use is strictly prohibited. Internet
communications are not secure and the University of Liverpool is not
responsible for their misuse or interception by third parties, or for any
possible alteration or data corruption in transmission or as a result of
computer viruses. University of Liverpool does not accept liability for
any errors or omissions in the contents of this message or any attachments
which arise as a result of the e-mail transmission.

 

References

Visible links
1. http://www.liv.ac.uk/files/docs/maps/liv...
3. http://www.liv.ac.uk/

foi Uof Liverpool, University of Liverpool

3 Attachments

 

[1]Mrs Lesley Jackson Freedom of Information Co-ordinator The Foundation
Building 765 Brownlow Hill Liverpool L69 7ZX E [University of Liverpool request email]
www.liverpool.ac.uk

 

FOI/LJ

 

1^st November 2018

 

 

Ms Sarai Keestra

Via email:   [2][FOI #525199 email]

 

 

Dear Ms Keestra,

 

Thank you for your email received 10^th October 2018 requesting
information concerning the assessment of the licensing and patenting
practices of the University of Liverpool.  I am pleased to provide the
requested information as set out below and attached:-

 

Q1. Has the university committed to licensing its medical discoveries in
ways that promote access and affordability in Low- and Middle- Income
Countries? If yes, please provide a link or PDF to the relevant policy
document.

 

Where possible the University will work to ensure its technologies are
available in LMIC however the University has not developed a formal policy
to cover this. Each project is considered on a case-by case basis.

 

Q2. Please provide an Excel spreadsheet with headings as displayed below
with all the health technologies LICENSED by the university in the past
year AND specify which countries they were licensed in AND specify whether
they are exclusive or non-exclusive licenses.

 

Health Technology Licensed | Country of Licensing | Type of License
(Exclusive or Non-Exclusive)

 

Attached

 

Q3. Please provide an Excel spreadsheet with all the health technologies
PATENTED by the university in the past year AND specify which countries
they were patented in.

 

Attached

 

Q4.Has the university shared its best practices for promoting access to
medicines through non-exclusive licensing by carrying out any of the
following activities?

- Contributed sample clauses to the AUTM Global Health Toolkit  No

- Published an article, guidance, or other literature on access licensing
practices No

- Formally presented on access licensing practices at an academic or
professional event, or at another university Yes

- Informally shared or discussed access licensing practices with
administrators at other universities Yes

- Other

- None

(Tick as appropriate)

 

Q5. What actions has the technology transfer office (TTO) undertaken in
the past year to improve access to the technologies they license in low-
and middle-income settings?

 

The University actively works with charities and local partners in low and
middle income countries to enable products to be developed for little or
no commercial return. The University does not adopt a blanket policy or
approach to licensing in LMIC as each project is evaluated on a
case-by-case basis. An example of this is the Baby Saver Tray developed by
Professor Andrew Weeks for the resuscitation of newborn babies, this was
developed in conjunction with the Sanyu Africa Research Institute (SAfRI)
in Eastern Uganda and will be available this year
[3]https://news.liverpool.ac.uk/2018/09/12/...

 

Another example is the Universities collaboration with the Medicines
Patent Pool (MPP) and a licence for the university’s Solid Drug
Nanoparticle (SDN) technology to accelerate the development of
WHO-recommended antiretrovirals as nanomedicines. The agreement covers a
territory of all 135 low- and middle-income countries and two high-income
countries in Africa, where licensees based anywhere in the world will have
the right to make, use and distribute lower cost ARVs based on SDN
technology.

 

If you are not satisfied with the University’s response to your request,
you may ask the University to review it.  If you wish to do this, please
write to the Freedom of Information Reviewer, Legal & Compliance, The
University of Liverpool, The Foundation Building, 765 Brownlow Hill,
Liverpool, L69 7ZX (email [4][University of Liverpool request email]), enclosing a copy of
your original request and explaining your complaint.  Please include an
address for correspondence.

 

If you remain dissatisfied with the handling of your request, you have a
right to appeal to the Information Commissioner at:-

 

The Information Commissioner’s Office, Wycliffe House, Water Lane,
Wilmslow, Cheshire, SK9 5AF.

Telephone:      0303 123 1113

Website: [5]www.ico.org.uk  

 

Yours sincerely,

 

Lesley Jackson

 

Freedom of Information Co-ordinator

 

 

show quoted sections